Spain reduces human consumption of antibiotics by 25% since 2014

Compilation
Since 2014 Spain reduced human consumption of antibiotics by 25.5% and 62.5% in animals to help prevent infections, according to the Ministry of Health. Thus, it is positioned as seventh countryof all those who submitted their consumption data to the ECDC, which further reduction in recent years, with a reduction of 27%, to achieve the European Union target (European Union) by 2030. In this context, Alliance Healthcare brought together health sector experts and representatives of the Madrid administration to discuss combating antimicrobial resistance and its evolution in Spain and in the world.

The meeting, which is the company’s second meeting dedicated to this topic after the first meeting held in Brussels in November 2022, provided an opportunity to analyze present and future challenges antimicrobial resistance, offering a common space for conversation on how to promote health, the sectors involved, the coordination and collaboration of the agents involved, both in terms of normative

as those who live with its consequences in their daily clinical practice.

Progressive antibiotic resistance due to overuse contributes to the development of infections in both humans and animals.

Experts recommend progressive contraction the need to use antimicrobial drugs through infection prevention in humans and animals, and to highlight the importance of raising awareness of the threat that antibiotic resistance poses to public health and promoting their judicious use in accordance with the National Plan to Combat Antibiotic Resistance (PRAN), coordinated by the Spanish Agency for Medicines and Health Products (AEMP). At the European level the opportunity review pharmaceutical legislation EU on the proposal of the European Commission on Pharmaceutical packagingincluding Council Recommendation for antimicrobial resistance (RAM).

To address the huge challenge of antimicrobial resistance, the event was split into two roundtable sessions. The first one was made up of Carmen MartinezPSOE Member of Congress and First Secretary of the Health Care Commission; Antonio LopezPRAN coordinator; Axel Balogh Manko Bük, Health Adviser in the European Parliament; And Paula Ceballosmedical analyst at the European Commission office in Madrid.

“Holding such events is important to educate the public on this issue. Moreover, we realized that it is important to approach this problem from the perspective Global Perspective

to provide a general response to all participating agents. We all need to be united to be able to move forward.”reflected Carmen MartinezMember of the PSOE in Congress and First Secretary of the Health Commission.

Experts recommend promoting the judicious use of antibiotics in accordance with the PRAN, coordinated by the Spanish Medicines and Health Products Agency.

The second roundtable discussed current issues in clinical practice and future challenges in the field. For this they took part Jordi VilaDirector of the Clinical Microbiology Service at the Clínic Hospital of Barcelona; Maria Cardenal IradierMember of the Commission on Antimicrobial Resistance of Farmaindustria; Pedro CarrascalCEO of the Patient Organizations Platform, and Maria ArizaPharmacist and Marketing Director of Alliance Healthcare Europe.

“ Innovation and research are needed to solve problems such as antibiotic resistance.. We have been working in this area for many years and making progress, but we still have a long way to go. To move forward, it is critical that we continue to research and find alternatives for clinical practice.”

stated Jordi VilaDirector of the Clinical Microbiology Service at the Clínic Hospital of Barcelona.

In its turn, Parra’s remedies, CEO of Alliance Healthcare Spain, stressed the importance of the meeting to highlight the role of everyone involved in the fight against antibiotic resistance. “We at Alliance Healthcare believe that it is very important to have a space where all points of view converge and from which we can draw points for improvement for the future. The problem of antibiotic resistance needs to be addressed from a global perspective., as we have done today, to chart a path forward to population health. “We will collaborate with all stakeholders, from healthcare professionals to researchers, health authorities and society at large, to achieve our ultimate goal of creating a healthier future.”completed.